Join Jérôme Pesenti, CEO BenevolentTech for a discussion on the impact the digital age is having on our society.
Solving the world’s most pressing challenges through open innovation and partnership.
Only 1 in 5,000 medicines in development make it to market, with a drug typically taking 12 years to develop from initial discovery to market. Estimates vary but the Association of the British Pharmaceutical Industry puts drug development at £1.15bn per drug.
Celebrate the establishment of the first international ChIPs Chapter on Thursday, 27 April 2017 from 5:30PM to 9:00PM at the Supreme Court building, London, United Kingdom. The festivities will include a panel discussion bringing together women leaders from the UK and US, followed by a reception.
Meet Ken Mulvany at Rutberg Summit presenting BenevolentAI's work on Artificial Intelligence applied to drug discovery
BenevolentAI Team will be attending the event, get in touch!
Committed to supporting the UK industry, IfM’s Centre for Technology Management (CTM) and Avidity IP launched the Strategic Intellectual Property Forum (SIPF) in 2015 to help companies understand how to manage and exploit their IP.
Join Jackie Hunter, CEO at BenevolentBio at the Pistoia Alliance Conference
To identify issues and discuss potential solutions around achieving best care and treatment for all patients with breast cancer
Join Professor Jackie Hunter who will present on “AI and Biomedicine: Culture clash or marriage made in heaven".
Join fellow developers, startups, academics and investors at the second edition of Project Juno's event to highlight the breadth and depth of machine intelligence activity and talent in Europe.
Panel Discussion : Can advanced analytics teach us to cure complex disease?
Professor Jackie Hunter has been invited to speak at this year's TechCrunch Disrupt event in London
NIPS is coming to Europe between 5th and 10th December in Barcelona – meet us there, talk to us about the world of AI and maybe joining the team
hosted by BenevolentAI
with Professor Jackie Hunter, CEO at Stratified Medical, a BenevolentAI company
Hosted by BenevolentAI
Internal Talk at BenevolentAI
by Dr Jeffrey Ng, CTO at BenevolentAI - IntelliSys 2015
with Dr John P. Overington, Director of Bioinformatics, BenevolentBio
Internal Talk at Stratified Medical — now known as BenevolentAI